Proteomic profiling identifies miR-423-5p as a modulator of oncogenic metabolism in HCC
Amalia Luce(University of Campania "Luigi Vanvitelli"), Michele Caraglia(University of Campania "Luigi Vanvitelli"), Rossella Sperlongano(University of Campania "Luigi Vanvitelli"), Luigi Mele(University of Campania "Luigi Vanvitelli"), Gabriella Misso(University of Campania "Luigi Vanvitelli"), Silvia Zappavigna(University of Campania "Luigi Vanvitelli"), David J. Boocock(Nottingham Trent University), Maria Preziosa Romano(University of Sannio), Ines Simeone(IRCCS Humanitas Research Hospital), Marco Bocchetti(University of Campania "Luigi Vanvitelli"), Clare Coveney(Nottingham Trent University), Alessia Maria Cossu(University of Campania "Luigi Vanvitelli"), Giovanni Vitale(University of Milan), Elisabetta Verderio(Nottingham Trent University), Maria Roberta De Iesu(University of Campania "Luigi Vanvitelli"), Madhura S. Tathode(University of Campania "Luigi Vanvitelli")
Cited by 1
Related Papers
A new inhibitor of glucose-6-phosphate dehydrogenase blocks pentose phosphate pathway and suppresses malignant proliferation and metastasis in vivo
|Cell Death and Disease|2018|215
Emerging anti-cancer molecular mechanisms of aminobisphosphonates
|Endocrine Related Cancer|2006|131
Glucose-6-phosphate dehydrogenase blockade potentiates tyrosine kinase inhibitor effect on breast cancer cells through autophagy perturbation
|Journal of Experimental & Clinical Cancer Research|2019|117
In Vivo Activity of MiR-34a Mimics Delivered by Stable Nucleic Acid Lipid Particles (SNALPs) against Multiple Myeloma
|PLoS ONE|2014|115
Long Non-coding RNAs as Important Biomarkers in Laryngeal Cancer and Other Head and Neck Tumours
|International Journal of Molecular Sciences|2019|94